NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

注射劑的全球市場 - 考察與預測,COVID-19的潛在影響:2021年∼2025年

Global Injectables Market: Insights & Forecast with Potential Impact of COVID-19 (2021-2025)

出版商 Koncept Analytics 商品編碼 1011013
出版日期 內容資訊 英文 127 Pages
訂單完成後即時交付
價格
注射劑的全球市場 - 考察與預測,COVID-19的潛在影響:2021年∼2025年 Global Injectables Market: Insights & Forecast with Potential Impact of COVID-19 (2021-2025)
出版日期: 2021年06月14日內容資訊: 英文 127 Pages
簡介

全球注射劑市場,2025年達到7,596億1,000萬美元,預計2021年∼2025年以10.95%的年複合成長率成長。老年人口增加,便利性高的藥物輸送的需求高漲,生物製藥的使用擴大,醫療費增加,癌症患者的劇增等要素,預計促進市場成長。

本報告提供全球注射劑市場相關調查分析,各市場區隔的市場分析,主要地區、主要國家市場,市場動態,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 市場概要

  • 簡介
  • 藥物給藥的非口服途徑
  • 非口服給藥途徑的種類
  • 注射劑的處方
  • 對注射劑的吸收的有利要素
  • 注射劑產品的種類
  • 注射劑的優點

第2章 COVID-19的影響

  • 注射劑的研究開發平台的投資擴大
  • 血漿療法的採用劇增
  • 智慧注射器的使用增加
  • 疫苗生產的加速

第3章 全球市場分析

  • 全球注射劑市場:各金額
  • 全球注射劑市場預測:各金額
  • 全球注射劑市場:各類型
    • 創新者
    • 非專利
    • 抗感染
    • 抗腫瘤 + 免疫調節
    • 消化管 + 代謝
    • 血液相關
    • 中樞神經系統
    • 肌肉骨骼系統
  • 全球注射劑市場:各地區
  • 全球非專利注射劑市場:各地區

第4章 各地區的市場分析

  • 北美
  • 歐洲
  • 中國
  • 印度
  • 其他地區

第5章 市場動態

  • 成長促進因素
  • 主要的趨勢與發展
  • 課題

第6章 競爭情形

  • 全球市場
    • 主要企業的收益比較
    • 主要企業的市值比較
    • 主要企業的研究開發比較
  • 北美市場
    • 美國的非專利注射劑市場金額佔有率:各主要企業
    • 美國的非專利注射劑市場數量佔有率:各主要企業

第7章 企業簡介

  • Novartis International AG
  • Pfizer Inc.
  • Fresenius SE & Co. KGaA
  • Baxter International Inc.
  • Shanghai Fosun Pharmaceutical Group Co. Ltd.(Gland Pharma Ltd.)
  • Hikma Pharmaceuticals PLC
目錄

The global injectables market is estimated to reach US$759.61 billion in 2025, progressing at a CAGR of 10.95%, over the period 2021-2025. Factors such as increasing geriatric population, upsurge in demand for convenient drug delivery, expanding use of biologics, rising healthcare expenditure and surging incidence of cancer cases would drive the growth of the market. However, the market growth would be challenged by stringent regulatory guidelines, emergence of alternative drug delivery methods and manufacturing complexity and high operational cost. A few notable trends may include accelerating prevalence of chronic diseases, growing adoption of self-injectable devices, upswing in drug shortages and advancements in technology.

Depending on the type, the global injectables market can be bifurcated into two main categories: innovator and generic. Further, generic injectables market can be split into Anti-Infectives (AI), Antineoplastics + Immunomodulators (AN+IM), Alimentary Tract + Metabolic (AT+Mb), Blood Related (BR), Central Nervous System (CNS), Musculoskeletal (Msk) and others, on the basis of therapy.

The fastest growing regional market is North America due to the improvements in healthcare infrastructure coupled with growing demand for injectables on account of high presence of a large number of patients with chronic diseases such as diabetes and arthritis which require frequent drug dosing and increasing research and development activities for the development of innovative injectables drugs. However, the market experienced a neutral growth due the outbreak of COVID-19 which moderately affected the production and clinical trials of various drugs.

Scope of the report:

  • The report provides a comprehensive analysis of the global injectables market segmented on the basis of type and region.
  • The major regional and country markets (North America, Europe, China, India and Rest of the World) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Novartis International AG, Pfizer Inc., Fresenius SE & Co. KGaA, Baxter International Inc., Shanghai Fosun Pharmaceutical Group Co. Ltd. (Gland Pharma Ltd.) and Hikma Pharmaceuticals PLC) are also presented in detail.

Key Target Audience:

  • Injectable Drug Manufacturers & Distributers
  • Pharmaceutical, Biopharmaceutical & Biotechnological Companies
  • End Users (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers & Others)
  • Research and Development (R&D) Organizations
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Parenteral Route of Drug Administration
  • 1.3 Types of Parenteral Routes of Administration
  • 1.4 Formulation of Injectable
  • 1.5 Factors Favoring the Absorption of Injectable Drugs
  • 1.6 Types of Injectable Drug Products
  • 1.7 Advantages of Injectable Drugs

2. Impact of COVID-19

  • 2.1 Growing Investments in the R&D Pipeline of Injectables
  • 2.2 Surging Adoption of Plasma Therapy
  • 2.3 Rising Usage of Smart Syringes
  • 2.4 Accelerating Vaccine Production

3. Global Market Analysis

  • 3.1 Global Injectables Market by Value
  • 3.2 Global Injectables Market Forecast by Value
  • 3.3 Global Injectables Market by Type
    • 3.3.1 Global Innovator Injectables Market by Value
    • 3.3.2 Global Innovator Injectables Market Forecast by Value
    • 3.3.3 Global Generic Injectables Market by Value
    • 3.3.4 Global Generic Injectables Market Forecast by Value
    • 3.3.5 Global Generic Injectables Market by Therapy
    • 3.3.6 Global Anti-Infective Injectables Market by Value
    • 3.3.7 Global Anti-Infective Injectables Market Forecast by Value
    • 3.3.8 Global Antineoplastic+ Immunomodulator Injectables Market by Value
    • 3.3.9 Global Antineoplastic+ Immunomodulator Injectables Market Forecast by Value
    • 3.3.10 Global Alimentary Tract + Metabolic Injectables Market by Value
    • 3.3.11 Global Alimentary Tract + Metabolic Injectables Market Forecast by Value
    • 3.3.12 Global Blood Related Injectables Market by Value
    • 3.3.13 Global Blood Related Injectables Market Forecast by Value
    • 3.3.14 Global Central Nervous System Injectables Market by Value
    • 3.3.15 Global Central Nervous System Injectables Market Forecast by Value
    • 3.3.16 Global Musculoskeletal Injectables Market by Value
    • 3.3.17 Global Musculoskeletal Injectables Market Forecast by Value
  • 3.4 Global Injectables Market by Region
  • 3.5 Global Generic Injectables Market by Region

4. Regional Market Analysis

  • 4.1 North America
    • 4.1.1 North America Injectables Market by Value
    • 4.1.2 North America Injectables Market Forecast by Value
    • 4.1.3 North America Generic Injectables Market Forecast by Value
    • 4.1.4 The U.S. Injectables Market by Value
    • 4.1.5 The U.S. Injectables Market Forecast by Value
    • 4.1.6 The U.S. Injectables Market by Type
    • 4.1.7 The U.S. Innovator Injectables Market Forecast by Value
    • 4.1.8 The U.S. Generic Injectables Market Forecast by Value
  • 4.2 Europe
    • 4.2.1 Europe Injectables Market by Value
    • 4.2.2 Europe Injectables Market Forecast by Value
    • 4.2.3 Europe Generic Injectables Market Forecast by Value
  • 4.3 China
    • 4.3.1 China Injectables Market by Value
    • 4.3.2 China Injectables Market Forecast by Value
    • 4.3.3 China Injectables Market by Type
    • 4.3.4 China Generic Injectables Market Forecast by Value
    • 4.3.5 China Innovator Injectables Market Forecast by Value
  • 4.4 India
    • 4.4.1 India Injectables Market by Value
    • 4.4.2 India Injectables Market Forecast by Value
    • 4.4.3 India Generic Injectables Market Forecast by Value
  • 4.5 RoW
    • 4.5.1 RoW Injectables Market by Value
    • 4.5.2 RoW Injectables Market Forecast by Value
    • 4.5.3 RoW Generic Injectables Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Increasing Geriatric Population
    • 5.1.2 Upsurge in Demand for Convenient Drug Delivery
    • 5.1.3 Expanding Use of Biologics
    • 5.1.4 Rising Healthcare Expenditure
    • 5.1.5 Surging Incidence of Cancer Cases
  • 5.2 Key Trends and Developments
    • 5.2.1 Accelerating Prevalence of Chronic Diseases
    • 5.2.2 Growing Adoption of Self-Injectable Devices
    • 5.2.3 Upswing in Drug Shortages
    • 5.2.4 Advancements in Technology
  • 5.3 Challenges
    • 5.3.1 Stringent Regulatory Guidelines
    • 5.3.2 Emergence of Alternative Drug Delivery Methods
    • 5.3.3 Manufacturing Complexity & High Operational Cost

6. Competitive Landscape

  • 6.1 Global Market
    • 6.1.1 Revenue Comparison of Key Players
    • 6.1.2 Market Capitalization Comparison of Key Players
    • 6.1.3 R&D Comparison of Key Players
  • 6.2 North America Market
    • 6.2.1 The U.S. Generic Injectables Market Value Share by Key Players
    • 6.2.2 The U.S. Generic Injectables Market Volume Share by Key Players

7. Company Profiles

  • 7.1 Novartis International AG
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Pfizer Inc.
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Fresenius SE & Co. KGaA
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Baxter International Inc.
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies
  • 7.5 Shanghai Fosun Pharmaceutical Group Co. Ltd. (Gland Pharma Ltd.)
    • 7.5.1 Business Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Business Strategies
  • 7.6 Hikma Pharmaceuticals PLC
    • 7.6.1 Business Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Business Strategies

List of Figures

  • Routes of Drug Administration
  • Types of Parenteral Routes of Administration
  • Factors Favoring the Absorption of Injectable Drugs
  • Types of Injectable Drug Products
  • Advantages of Injectable Drugs
  • Percentage of Drugs in R&D Pipeline Worldwide by Delivery Route (2020)
  • Global Plasma Therapy Market Forecast (2019-2024)
  • Global Smart Syringes Market (2018-2027)
  • Reported Vaccine Production Capacity (Q4 2020-2023)
  • Global Injectables Market by Value (2016-2020)
  • Global Injectables Market Forecast by Value (2021-2025)
  • Global Injectables Market by Type (2020)
  • Global Innovator Injectables Market by Value (2016-2020)
  • Global Innovator Injectables Market Forecast by Value (2021-2025)
  • Global Generic Injectables Market by Value (2016-2020)
  • Global Generic Injectables Market Forecast by Value (2021-2025)
  • Global Generic Injectables Market by Therapy (2020)
  • Global Anti-Infective Injectables Market by Value (2016-2020)
  • Global Anti-Infective Injectables Market Forecast by Value (2021-2025)
  • Global Antineoplastic+ Immunomodulator Injectables Market by Value (2016-2020)
  • Global Antineoplastic+ Immunomodulator Injectables Market Forecast by Value (2021-2025)
  • Global Alimentary Tract + Metabolic Injectables Market by Value (2016-2020)
  • Global Alimentary Tract + Metabolic Injectables Market Forecast by Value (2021-2025)
  • Global Blood Related Injectables Market by Value (2016-2020)
  • Global Blood Related Injectables Market Forecast by Value (2021-2025)
  • Global Central Nervous System Injectables Market by Value (2016-2020)
  • Global Central Nervous System Injectables Market Forecast by Value (2021-2025)
  • Global Musculoskeletal Injectables Market by Value (2016-2020)
  • Global Musculoskeletal Injectables Market Forecast by Value (2021-2025)
  • Global Injectables Market by Region (2020)
  • Global Generic Injectables Market by Region (2020)
  • North America Injectables Market by Value (2016-2020)
  • North America Injectables Market Forecast by Value (2021-2025)
  • North America Generic Injectables Market Forecast by Value (2020-2025)
  • The U.S. Injectables Market by Value (2016-2020)
  • The U.S. Injectables Market Forecast by Value (2021-2025)
  • The U.S. Injectables Market by Type (2020)
  • The U.S. Innovator Injectables Market Forecast by Value (2020-2025)
  • The U.S. Generic Injectables Market Forecast by Value (2020-2025)
  • Europe Injectables Market by Value (2016-2020)
  • Europe Injectables Market Forecast by Value (2021-2025)
  • Europe Generic Injectables Market Forecast by Value (2020-2025)
  • China Injectables Market by Value (2016-2020)
  • China Injectables Market Forecast by Value (2021-2025)
  • China Injectables Market by Type (2020)
  • China Generic Injectables Market Forecast by Value (2020-2025)
  • China Innovator Injectables Market Forecast by Value (2020-2025)
  • India Injectables Market by Value (2016-2020)
  • India Injectables Market Forecast by Value (2021-2025)
  • India Generic Injectables Market Forecast by Value (2020-2025)
  • RoW Injectables Market by Value (2016-2020)
  • RoW Injectables Market Forecast by Value (2021-2025)
  • RoW Generic Injectables Market Forecast by Value (2020-2025)
  • Global Population 65 Years and Above (2016-2020)
  • Global Spending on Injectables (2015 v/s 2020)
  • Global Biologics Market Revenue (2016-2022)
  • Global Healthcare Expenditure Per Capita (2016-2020)
  • Global Cancer Prevalence (2018-2023)
  • Global Diabetes Prevalence (2010-2045)
  • Distribution of the Global Injectable Drug Delivery Market by Device (2016 v/s 2025)
  • Percentage of New Drug Shortages in the U.S. (2016-2020)
  • The U.S. Generic Injectables Market Value Share by Key Players (2020)
  • The U.S. Generic Injectables Market Volume Share by Key Players (2020)
  • Novartis International AG Net Sales and Net Income (2016-2020)
  • Novartis International AG Net Sales by Segment (2020)
  • Novartis International AG Net Sales by Region (2020)
  • Pfizer Inc. Total Revenue and Net Income (2016-2020)
  • Pfizer Inc. Revenue by Region (2020)
  • Fresenius SE & Co. KGaA Sales and Net Income (2016-2020)
  • Fresenius SE & Co. KGaA Sales by Segment (2020)
  • Fresenius SE & Co. KGaA Sales by Region (2020)
  • Baxter International Inc. Net Sales and Net Income (2016-2020)
  • Baxter International Inc. Net Sales by Region (2020)
  • Shanghai Fosun Pharmaceutical Group Co. Ltd. Revenue and Profit (2016-2020)
  • Shanghai Fosun Pharmaceutical Group Co. Ltd. Revenue by Segment (2020)
  • Shanghai Fosun Pharmaceutical Group Co. Ltd. Revenue by Region (2020)
  • Hikma Pharmaceuticals PLC Revenue and Profit (2016-2020)
  • Hikma Pharmaceuticals PLC Revenue by Segment (2020)
  • Hikma Pharmaceuticals PLC Revenue by Region (2020)

List of Tables

  • Revenue Comparison of Key Players (2020)
  • Market Capitalization Comparison of Key Players (2021)
  • R&D Comparison of Key Players (2020)